Background There are increasing data on the association between non‐alcoholic fatty liver
disease (NAFLD) and cardiovascular diseases (CVD). Aim To summarise evidence on the …

Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver
disease in the United States and worldwide. The progressive form of NAFLD, nonalcoholic …

Metabolism-associated fatty liver disease (MAFLD) is a multifaceted disease that involves
complex interactions between various organs, including the gut and heart. It is defined by …

Non-alcoholic fatty liver disease (NAFLD) represents the hepatic expression of the metabolic
syndrome and is the most prevalent liver disease. NAFLD is associated with liver-related …

Whether non-alcoholic fatty liver disease (NAFLD) is a cardiovascular (CV) risk factor is
debated. We performed a systematic review and meta-analysis to assess the CV morbidity …

Hyperlipidemia, high levels of blood lipids including cholesterol and triglycerides, is a major
risk factor for cardiovascular disease. Traditional treatments of hyperlipidemia often include …

Non-alcoholic fatty liver disease is one of the main liver diseases worldwide. The most
common cause of death in patients with nonalcoholic fatty liver disease is cardiovascular …

Non-alcoholic fatty liver disease (NAFLD) prevalence has increased drastically in recent
decades, affecting up to 25% of the world's population. NAFLD is a spectrum of different …

Background Hypercholesterolemia is an independent modifiable risk factor that accelerates
the development of both non-alcoholic fatty liver and atherosclerosis. Coconut water …

Diagnostic delay in type 2 diabetes mellitus (T2DM) with nonalcoholic fatty liver disease
(NAFLD) patients often leads to a serious public health problem. Understanding the …